Challenges of pancreatic cancer chemotherapy in the COVID-19 era

J Gastrointestin Liver Dis. 2020 Jun 4;29(2):273-275. doi: 10.15403/jgld-2527.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Betacoronavirus*
  • COVID-19
  • Capecitabine / therapeutic use*
  • Coronavirus Infections / prevention & control*
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Female
  • Fluorouracil / therapeutic use
  • Gemcitabine
  • Humans
  • Irinotecan / therapeutic use
  • Leucovorin / therapeutic use
  • Male
  • Middle Aged
  • Oxaliplatin / therapeutic use*
  • Pancreatic Neoplasms / drug therapy*
  • Pandemics / prevention & control*
  • Pneumonia, Viral / prevention & control*
  • Romania
  • SARS-CoV-2

Substances

  • Antineoplastic Agents
  • folfirinox
  • Oxaliplatin
  • Deoxycytidine
  • Capecitabine
  • Irinotecan
  • Leucovorin
  • Fluorouracil
  • Gemcitabine